PROLOR BIOTECH, INC. Net Change in Cash
PROLOR BIOTECH, INC. reported Net Change in Cash of $19.02 million for the 97-month period ending 2013-06-30, per its 10-Q filed 2013-08-09.
Discontinued › Cash Flow
us-gaap:CashAndCashEquivalentsPeriodIncreaseDecrease · last filed 2013-08-09
- PROLOR BIOTECH, INC. cash and cash equivalents, period increase (decrease) for the quarter ending 2013-06-30 was -$5.71M, a 129.47% decline year-over-year.
- PROLOR BIOTECH, INC. cash and cash equivalents, period increase (decrease) for the quarter ending 2013-03-31 was $876.46K.
- PROLOR BIOTECH, INC. cash and cash equivalents, period increase (decrease) for the quarter ending 2012-12-31 was -$4.72M.
- PROLOR BIOTECH, INC. cash and cash equivalents, period increase (decrease) for the quarter ending 2012-09-30 was $1.95M.
- PROLOR BIOTECH, INC. cash and cash equivalents, period increase (decrease) for fiscal 2012 was $10.59M.
- PROLOR BIOTECH, INC. cash and cash equivalents, period increase (decrease) for fiscal 2011 was -$10.82M, a 152.46% decline from fiscal 2010.
- PROLOR BIOTECH, INC. cash and cash equivalents, period increase (decrease) for fiscal 2010 was $20.63M.
- PROLOR BIOTECH, INC. cash and cash equivalents, period increase (decrease) for fiscal 2009 was -$3.98M.
| Period end | Cash and Cash Equivalents, Period Increase (Decrease) 3 month | Cash and Cash Equivalents, Period Increase (Decrease) 6 month | Cash and Cash Equivalents, Period Increase (Decrease) 9 month | Cash and Cash Equivalents, Period Increase (Decrease) 12 month | Cash and Cash Equivalents, Period Increase (Decrease) 73 month | Cash and Cash Equivalents, Period Increase (Decrease) 76 month | Cash and Cash Equivalents, Period Increase (Decrease) 79 month | Cash and Cash Equivalents, Period Increase (Decrease) 82 month | Cash and Cash Equivalents, Period Increase (Decrease) 85 month | Cash and Cash Equivalents, Period Increase (Decrease) 88 month | Cash and Cash Equivalents, Period Increase (Decrease) 91 month | Cash and Cash Equivalents, Period Increase (Decrease) 94 month | Cash and Cash Equivalents, Period Increase (Decrease) 97 month |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2013-06-30 | -$5.71M derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-09 | -$4.83M 10-Q · filed 2013-08-09 | -$9.55M derived: sum of 3 quarters · filed 2013-08-09 | -$7.60M derived: sum of 4 quarters · filed 2013-08-09 | $19.02M 10-Q · filed 2013-08-09 | ||||||||
| 2013-03-31 | $876.46K 10-Q · filed 2013-05-10 | -$3.85M derived: sum of 2 quarters · filed 2013-05-10 | -$1.89M derived: sum of 3 quarters · filed 2013-05-10 | $17.48M derived: sum of 4 quarters · filed 2013-08-09 | $24.73M 10-Q · filed 2013-05-10 | ||||||||
| 2012-12-31 | -$4.72M derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-15 | -$2.77M derived: sum of 2 quarters · filed 2013-03-15 | $16.60M derived: sum of 3 quarters · filed 2013-08-09 | $10.59M 10-K · filed 2013-03-15 | $23.85M 10-K · filed 2013-03-15 | ||||||||
| 2012-09-30 | $1.95M derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-08 | $21.32M derived: sum of 2 quarters · filed 2013-08-09 | $15.31M 10-Q · filed 2012-11-08 | $13.00M derived: sum of 4 quarters · filed 2013-08-09 | $28.57M 10-Q · filed 2012-11-08 | ||||||||
| 2012-06-30 | $19.37M derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-09 | $13.36M 10-Q · filed 2013-08-09 | $11.04M derived: sum of 3 quarters · filed 2013-08-09 | $11.00M derived: sum of 4 quarters · filed 2013-08-09 | $26.62M 10-Q · filed 2012-08-09 | ||||||||
| 2012-03-31 | -$6.01M 10-Q · filed 2013-05-10 | -$8.32M derived: sum of 2 quarters · filed 2013-05-10 | -$8.37M derived: sum of 3 quarters · filed 2013-05-10 | -$14.69M derived: sum of 4 quarters · filed 2013-05-10 | $7.25M 10-Q · filed 2012-05-04 | ||||||||
| 2011-12-31 | -$2.31M derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-15 | -$2.36M derived: sum of 2 quarters · filed 2013-03-15 | -$8.68M derived: sum of 3 quarters · filed 2013-03-15 | -$10.82M 10-K · filed 2013-03-15 | $13.26M 10-K/A · filed 2012-03-23 | ||||||||
| 2011-09-30 | -$44.14K derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-08 | -$6.37M derived: sum of 2 quarters · filed 2012-11-08 | -$8.51M 10-Q · filed 2012-11-08 | -$821.82K derived: sum of 4 quarters · filed 2013-03-15 | $15.97M 10-Q · filed 2011-11-09 | ||||||||
| 2011-06-30 | -$6.32M derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-09 | -$8.46M 10-Q · filed 2012-08-09 | -$777.68K derived: sum of 3 quarters · filed 2013-03-15 | -$3.41M derived: sum of 4 quarters · filed 2013-03-15 | $16.01M 10-Q · filed 2011-08-09 | ||||||||
| 2011-03-31 | -$2.14M 10-Q · filed 2012-05-04 | $5.55M derived: sum of 2 quarters · filed 2013-03-15 | $2.91M derived: sum of 3 quarters · filed 2013-03-15 | ||||||||||
| 2010-12-31 | $7.69M derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-15 | $5.05M derived: sum of 2 quarters · filed 2013-03-15 | $20.63M 10-K · filed 2013-03-15 | ||||||||||
| 2010-09-30 | -$2.64M derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-09 | $12.94M 10-Q · filed 2011-11-09 | |||||||||||
| 2010-06-30 | $15.58M 10-Q · filed 2011-08-09 | ||||||||||||
| 2009-12-31 | -$3.98M 10-K/A · filed 2012-03-23 |